Point of Care (PoC) Diagnostics Market Size Worth $115.44 Billion By 2032 | CAGR: 9.40%

The global point of care (PoC) diagnostics market size is expected to reach USD 115.44 billion by 2032, according to a new study by Polaris Market Research. The report “Point of Care (PoC) Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product; By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays); By End-Use; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growth of the Point-of-Care (POC) diagnostics industry attributed by, there has been a significant increase in the prevalence of infectious diseases over the past decade. This rise has created a higher demand for rapid and accurate diagnostic tests that can be performed at the point of care, enabling immediate treatment decisions and reducing the spread of these diseases.

Technological advancements have also played a crucial role in the growth of the POC diagnostics industry. With the development of innovative and user-friendly devices, patients can now receive healthcare services at home. This is particularly important for the geriatric population, who may struggle to access traditional healthcare settings. POC diagnostics enable convenient and timely healthcare delivery, improving patient outcomes and reducing the burden on healthcare systems.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/point-of-care-poc-diagnostics-market/request-for-sample

The market is experiencing notable trends and developments due to the growing adoption of rapid diagnostic tests (RDTs) and their quick and on-site results, which are particularly valuable in emergency and remote healthcare settings. Technological advancements, such as miniaturization and smartphone integration, have improved the performance and accessibility of point-of-care devices. Additionally, there is an increased focus on infectious disease testing, with point-of-care tests being crucial in rapidly identifying pathogens like COVID-19, malaria, and influenza.

In addition, the shift towards personalized medicine is leveraging point-of-care diagnostics. Real-time patient data and immediate test results enable healthcare professionals to make tailored treatment decisions based on individual needs, optimizing patient care. Chronic disease management, including diabetes and cardiovascular diseases, also benefits from point-of-care diagnostics, allowing for regular biomarker monitoring and timely intervention. Moreover, the market is expanding into home healthcare, where patients can perform certain tests themselves, empowering them and facilitating remote monitoring.

Point of Care (PoC) Diagnostics Market Report Highlights

• The glucose testing segment accounted for the largest share of the market due to the increasing prevalence of diabetes and related conditions.
• The clinics segment dominated the market with the highest revenue shares due to the increasing development of PoC diagnostics laboratory centers within clinics.
• North American region holds the largest revenue shares of the market in 2022 due to there is the presence of well-established key players in this region and their contribution to market expansion. Also, government sponsors various research bodies.
• The global key market players include Siemens Healthineers, Roche Diagnostics, Chembio Diagnostic Systems, Johnson & Johnson, Abbott Laboratories, Becton, Dickinson and Company, Instrumentation Laboratory Company, and others.

Polaris Market Research has segmented the Point of Care (PoC) Diagnostics market report based on product, platform, end-use, and region:

Point of Care (PoC) Diagnostics, Product Outlook (Revenue - USD Billion, 2019 - 2032)

• Glucose Testing
• Hb1Ac Testing
• Coagulation
• Fertility
• Infectious Diseases

• HIV
• Clostridium Difficile
• HBV
• Pneumonia or Streptococcus Associated Infections
• Respiratory Syncytial Virus (RSV)
• HPV
• Influenza/Flu
• HCV
• MRSA
• TB and Drug-Resistant TB
• HSV
• Others

• Cardiac Markers
• Thyroid Stimulating Hormone
• Hematology
• Primary Care Systems
• Decentralized Clinical Chemistry
• Feces
• Lipid Testing
• Cancer Marker
• Blood Gas/Electrolytes
• Ambulatory Chemistry
• Drug Abuse Testing
• Urinalysis

Point of Care (PoC) Diagnostics, Platform Outlook (Revenue - USD Billion, 2019 - 2032)

• Lateral Flow Assays
• Dipsticks
• Microfluidics
• Molecular Diagnostics
• Immunoassays

Point of Care (PoC) Diagnostics, End-use Outlook (Revenue - USD Billion, 2019 - 2032)

• Clinics

• Physician Office
• Pharmacy & Retail Clinics
• Non-practice Clinics
• Urgent Care Clinic

• Hospitals
• Home
• Assisted Living Healthcare Facilities
• Laboratory

Point of Care (PoC) Diagnostics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

• North America

• U.S.
• Canada

• Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands

• Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia

• Latin America

• Argentina
• Brazil
• Mexico

• Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa

Point of Care (PoC) Diagnostics Market Report Scope